Jubilant Pharmova to invest in the French R&D center of Pierre Fabre.

Synopsis

Jubilant Pharmova, an integrated global company engaged in pharmaceuticals and drug discovery & development solutions businesses, agreed to invest in the French R&D center of Pierre Fabre, a French pharmaceutical and dermo-cosmetic group. Financial terms were not disclosed.

Principals

target

Pierre Fabre (french R&d Center)

bidder

Jubilant Pharmova

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

Sort

Bidder Team (3)

priyavrat bhartia

Managing Director at JUBILANT PHARMOVA

Manager

bidder

Deal

n/a

Total Value

ermine bolot

Partner at Dechert

Lawyer

bidder

Deals

£ 3.09 B

Total Value

sophie pele

National Partner at Dechert

Lawyer

bidder

Deals

£ 2.45 B

Total Value

Vendor Team (1)

eric ducournau

CEO at GROUPE PIERRE FABRE

Manager

vendor

Deals

n/a

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy